Astrazeneca AZN
NYSE AZN
$163.70 +3.53 (+2.20%)
As of: Sep 14, 2026 · 3:06 PM EDT

Astrazeneca (AZN) Cash from Operations Growth (5y) (2014 - 2026)

Analysis

Astrazeneca (AZN) Cash from Operations Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Asml Holding 618.78 Bn 602.80 Bn 5.90 Bn
2 Hsbc Holdings 362.62 Bn 362.62 Bn -
3 General Electric 329.79 Bn 320.45 Bn 6.95 Bn
4 Astrazeneca 253.78 Bn 248.49 Bn 12.86 Bn
5 Citigroup 228.38 Bn -2,073.93 Bn 24.75 Bn
6 Bhp 216.07 Bn 197.52 Bn -
7 Rio Tinto 203.71 Bn 199.33 Bn -
8 Diageo 197.09 Bn 195.06 Bn -
9 Unilever 139.31 Bn 132.28 Bn -
10 Hdfc Bank 117.84 Bn 80.69 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.29%
Mar 31, 2026 11.67%
Dec 31, 2025 5.43%
Sep 30, 2025 23.02%
Jun 30, 2025 26.63%
Mar 31, 2025 92.90%
Dec 31, 2024 42.72%
Sep 30, 2024 25.13%
Jun 30, 2024 28.57%
Mar 31, 2024 53.14%
Dec 31, 2023 29.07%
Jun 30, 2023 92.50%
Mar 31, 2023 89.41%
Dec 31, 2022 49.36%
Jun 30, 2022 13.28%
Mar 31, 2022 56.98%
Dec 31, 2021 -14.20%
Sep 30, 2021 16.21%
Jun 30, 2021 37.57%
Mar 31, 2021 10.14%